Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

136.44 -0.84 (-0.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,823,630
Open 136.86
Bid (Size) 134.50 (1)
Ask (Size) 137.99 (1)
Prev. Close 137.28
Today's Range 134.80 - 137.22
52wk Range 127.37 - 248.87
Shares Outstanding 146,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors
From Lowey Dannenberg, P.C.
Via GlobeNewswire
Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday
Piper Sandler cut the price target for Accenture plc (NYSE: ACN) from $312 to $300. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Accenture shares rose 0.3% to $301.56 in pre-market... 
Via Benzinga

Performance

YTD
-32.08%
-32.08%
1 Month
-14.42%
-14.42%
3 Month
-27.47%
-27.47%
6 Month
-40.68%
-40.68%
1 Year
-27.13%
-27.13%

More News

Read More
Expert Ratings for Illumina
Via Benzinga
September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average
Via Benzinga
Topics Stocks
Exposures US Equities
How Is The Market Feeling About Illumina?
Via Benzinga
Is the Worst Over for Illumina Stock?
Via The Motley Fool
$100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
Via Benzinga
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
From Myriad Genetics, Inc.
Via GlobeNewswire
11 Analysts Have This to Say About Illumina
Via Benzinga
Cramer Is 'Astonished' That Chewy Is 'Doing This Poorly — So Many Of Us Use It'
Via Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Did Elon Musk Admit 90% Decline In Twitter's Value Since Acquisition?, Apple's Zero-Click Vulnerabilities Uncovered By Internet Watchdog Group, Gas Prices Jump As Strikes Start At Major Chevron Australia LNG Projects: Today's Top Stories
Via Benzinga
Peering Into Illumina's Recent Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Via Benzinga
Elliott Wave Technical Analysis: Illumina Inc.
Via Talk Markets
Billionaire Activist Investor Carl Icahn Shows Support For Illumina's Newly Appointed CEO
Via Benzinga
Cathie Wood's Buying These 3 Stocks Hand Over Fist
Via The Motley Fool
Why Is Illumina Stock Trading Lower Today?
Via Benzinga
Wall Street Thinks Illumina Stock Will Rise 27% in 1 Year. Here's Why That Probably Won't Happen.
Via The Motley Fool
Down 15% in 2023, Should You Buy the Dip With Illumina Stock?
Via The Motley Fool
The Latest Analyst Ratings for Illumina
Via Benzinga
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Illumina Shares Are Falling Today
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Illumina To Bear The Brunt Of Slowdown In Consumables Purchasing Amid Lower Demand In China: Analyst
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.